DOI: 10.1055/s-00000007

Aktuelle Urologie

References

Clarke N, Wiechno P, Alekseev B. et al.
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet Oncology 2018;
19: 975-986

Download Bibliographical Data

Search in:
Access: